Locoregional cancer therapy using polymer-based drug depots

Area of Science:

• Oncology
• Biomaterials Science
• Drug Delivery Systems

Background:

• Intravenous chemotherapy causes significant adverse effects.
• Locoregional drug delivery aims to improve treatment efficacy and reduce systemic toxicity.
• Polymer-based drug depots enable sustained local drug release at the tumor site.

Purpose of the Study:

• To review studies on the application of drug-eluting depots for local cancer treatment.
• To highlight the potential of these depots in preventing tumor recurrence post-surgery.
• To summarize clinical and preclinical evidence for various cancer types.

Main Methods:

• Literature review of studies utilizing polymer-based drug-eluting depots for cancer therapy.
• Analysis of applications in different cancer types and delivery routes (intratumoral, adjacent, inhaled, intraperitoneal).
• Evaluation of reported clinical success and preclinical proof-of-concept.

Main Results:

• Drug-eluting depots provide long-term local drug exposure, minimizing systemic side effects.
• Clinical success demonstrated for brain and liver cancer treatments.
• Preclinical studies show promise for lung and abdominal cancers using inhaled and intraperitoneal depots, respectively.
• Depots are frequently used to prevent tumor recurrence after surgical resection.

Conclusions:

• Polymer-based drug depots represent a promising strategy for locoregional cancer therapy.
• Sustained local drug delivery via depots can enhance treatment outcomes and reduce toxicity.
• Further research and clinical translation are warranted for various cancer types and delivery modalities.